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 Abstract 
 
Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) 3 proteins 
have been identified as potent viral DNA mutators and have broad antiviral activity. In 
this study, we demonstrated APOBEC3A (A3A) and A3G expression levels were 
significantly upregulated in HPV infected cell lines and tissues. Heat treatment 
resulted in elevated expression of A3A and A3G in a temperature-dependent manner 
in HPV infected cells. Correspondingly, 44 ºC heating treated HPV infected cells 
showed accumulated G-to-A or C-to-T mutation in HPVE2 gene. Knockdown of A3A 
or A3G could promote cell viability, along with the lower frequency of A/T in HPV 
E2 gene. In addition, regressing genital viral warts also harbored high G-to-A or 
C-to-T mutation in HPVE2 gene. Taken together, we demonstrate that APOBEC3 
expression and editing function was heat sensitive to a certain degree, partly 
explaining the mechanism of action of local hyperthermia to treat viral warts.  
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 Introduction 
 
Human papillomavirus (HPV) is a group of small, nonenveloped and 
double-stranded DNA viruses found in a variety of proliferative and some malignant 
lesions of epithelial origin (Shterzer et al., 2014). HPVs are the primary etiological 
agents of several clinical entities (Giannaki et al., 2013). Condyloma acuminate(CA) 
is a common sexually transmitted HPV infection in the external genital and perianal 
areas. Local hyperthermia has been successfully used in the treatment of 
HPV-infected skin lesions, with cure rates ranging from 41% to 93.5% according to 
differences in hyperthermia conditions, therapeutic procedure and responsiveness of 
specific conditions (Ma et al., 2012). It has been presumed that local hyperthermia 
can directly influence virus activity, and promote host immune responses to eliminate 
HPV infections (Li et al., 2009; Ma et al., 2012; Wang et al., 2010; Zhu et al., 2010).  
 
Apolipoprotein B mRNA-editing catalytic polypeptide (APOBEC) deaminases 
are a family of protein that edit DNA and/or RNA sequence, which include 
activation-induced cytidine deaminase（AID）, APOBEC1,- 2, -3A, -3B, -3C, -3DE, 
-3F, -3G, -3H and -4. Depending on cell type and tissue environment, the expression 
and localization of APOBECs are different (Moris et al., 2014; Vieira and Soares, 
2013). APOBEC family displays deteriorating genetic information of many viruses by 
hypermutaion-dependent and –independent approach. Recently, several high-profile 
studies suggested that APOBEC3-mediated mutagenesis is highly enriched in 
HPV-positive cervical and head-and-neck cancers (Burns et al., 2013; Roberts et al., 
2013). In addition, two human APOBEC3A (A3A) and A3G gene are expressed in 
epithelial cells and both of them are reported to be involved in editing HPV by 
inducing cytidine (C) to uracil (U) hypermutation (Vartanian et al., 2008; Wang et al., 
2014). 
 
Interferons (IFNs) and LPS could positively regulate A3 expression by different 
pathways (Mehta et al., 2012). The expression of A3 has been determined based on 
mRNA levels in cells, using quantitative PCR (Koning et al., 2009; Refsland et al., 
2010). While an extremely sensitive PCR method, differential DNA denaturation PCR 
(3D-PCR), has detected hypermutations from C to T or G to A (Kukimoto and 
Muramatsu, 2015). Here, we detected the expression of A3A and A3G in HPV 
infected cells, and further tested whether local hyperthermia could affect A3A and 
A3G expression in HPV infected cells, and subsequent gene editing of susceptible 
HPV genes.  
 
 
 
 
 
 
 Results 
 
Expression of A3A and A3G is elevated in CA than in normal skin 
By immunohistochemical staining, we observed that A3A was slightly expressed 
in keratinocytes from normal skin; however, there was much stronger expression of 
A3A in CA tissues than in normal skin (Figure 1a). A3G was either very weak or 
negative in normal skin; however, a strong expression of A3G was observed in most 
of CA samples (Figure 1b). The mean optical density of A3A and A3G in CA was 
higher than normal skin tissue by analysis with Image-Pro plus software. 
 
Heat/Hyperthermia induced up-regulation of A3A and A3G in HPV harboring 
cells and the skin  
Five cervical cell lines were used. C33A and HT3 are negative for HPV, SiHa 
harbors 1-2 copies of HPV16, CaSki harbors about 60-600 copies of HPV16 and 
HeLa harbors HPV18 (Baker et al., 1987; Ostrowska et al., 2010; Pattillo et al., 1977; 
Yee et al., 1985; Choi et al., 2005). As shown in Figure 2a and b, hyperthermia at 42 
ºC and 45 ºC induced 7- and 14- fold increase of A3A mRNA, and 14- and 60- fold 
increase of A3G, respectively, in CaSki cells. Hyperthermia at 42 ºC and 45 ºC also 
induced 3-4 fold increase of A3A and A3G mRNA in SiHa cells. Hyperthermia on 
C33A cells, however, did not induce any significant change of A3A and A3G. Western 
blotting confirmed the significant elevated expression of A3A and A3G in CaSki cells, 
moderately elevated expression in SiHa cells and no obvious changed expression in 
C33A cells (Figure 2c). The expression of A3A and A3G induced by hyperthermia in 
HeLa and HT3 cell lines was presented in Supplementary Figure S1a-b. 
 
We collected 11 surgically removed samples from CA patients and divided each 
sample into equal three parts. Each part from a patient was subjected to hyperthermia 
at 37 ºC, 42 ºC and 45 ºC for 30 min as described (Ostberg et al., 2003; Wang et al., 
2009; Zhu et al., 2010). Real-time PCR analysis showed that there was a significant 
increase in the production of A3A and A3G transcripts in CA tissue subjected to local 
hyperthermia. There was a 2-3 and 11-13 fold-increase of A3A transcripts in CA 
tissues subjected to hyperthermia at 42 ºC and 45 ºC, respectively, as compared with 
that at 37 ºC (Figure 2d); the increase of A3G transcript level was 4-6 and 10-12 fold 
when subjected to hyperthermia at 42 ºC and 45 ºC, as compared to that of 37 ºC, 
respectively (Figure 2e). The expression levels of A3A and A3G remained stable in 
normal skin, regardless of hyperthermia temperature employed.  
 
Taken together, hyperthermia further elevated the expression levels of A3A and 
A3G in HPV infected cells, and the effects appeared in a temperature- dependent. It is 
also demonstrated that cells with high HPV copy number had stronger A3A and A3G 
expression when subjected to hyperthermia. 
 
Heat induced hypermutation of E2 gene in cervical cancer cells 
A3 proteins have been identified as a restriction factor against HPV infection by 
editing viral DNA (Kukimoto et al., 2015; Warren et al., 2015). We investigated 
whether overexpression of A3A and A3G induced by heat in cervical cancer cells 
could mutate HPV E2 sequence. First, we applied 3D-PCR assay to detect the present 
of G→A or C→T hypermutation by decreasing the denaturation temperature. The 
mutation of E2 gene could undermine E2 gene functions, directly or indirectly 
affecting development and final outcome of HPV-associated diseases (McBride, 2013; 
Xue et al., 2015a). The E2 genes from CaSki cells subjected to heat at 44 ºC were 
amplified at a relatively lower denaturation temperature (83.7 ºC) than those at 37 ºC 
(85.5 ºC). As with CaSki cells, SiHa cells heat-treated at 44 ºC yielded the PCR 
products at a lower denaturation temperature (84.1 ºC) compared to those without 
undergoing heating (85.5 ºC).The results indicated that mutation frequency in CaSki 
cells was probably higher than that in SiHa cells after heating at 44 ºC (Figure 3a).  
 
To detect the presence of E2 hypermutation, amplified E2 fragments at the 
lowest denaturation temperature were excised from gels and inserted into a T vector 
for sequence determination. Sequence analysis revealed CaSki cells and SiHa cells 
treated with heat exhibited a robust preference for C to T or G to A hypermutation in 
the coding-strand of HPV E2 gene. Amplified E2 gene carried 12 G to A mutations, 
18 C to T mutations in CaSki cells, and 9 G to A mutations, 12 C to T mutations in 
SiHa cells, respectively (Figure 3b). E2 DNA amplified and sequence analysis in HT3 
and HeLa cells treated or untreated with heat were presented in Supplementary Figure 
S1c-d. These results collectively demonstrated that heat boosted- high- expression of 
A3A and 3G contributed to E2 hypermutation in cervical cancer cells. It was 
intriguing to note that E6 hypermutation was not significantly different among the 
treated cell lines (data not shown), while if other open reading frames of HPV are 
susceptible remains further investigation. 
 
Regressing CA lesions had elevated mRNA expression of A3A and A3G  
We previously reported local hyperthermia at a small part of an extensive CA 
patient resulted in clearance of all the lesions. During the regression of lesions, there 
was dense infiltration of CD8+T cells as well as CD4+T cells at the untreated lesional 
sites, 2-4 weeks post initiation of the treatment. Their number returned to near normal 
value at week 6 (Huo et al., 2013). Following similar protocol as reported (Huo et al., 
2013), we took serial biopies specimens from six patients with multiple CA lesions, 
who received five sessions of local hyperthermia at 44 ºC for 30mins each, at one part 
of the lesions. Each of the patients we collected was recorded his/her gender, age, 
number of warts and HPV subtype (Supplementary Table S1). Biopsies were taken on 
untreated area before and 2-, 6- weeks after the first treatment. Four of the patients 
showed signs of clinical regression at week 6 post treatment, one patient (P4) had all 
her lesions resolved at week 4. As shown in Fig.4a and b, the mRNA expression of 
A3A and A3G increased during the regression course of the lesions. In the case of the 
patient who failed to respond to hyperthermia treatment clinically, we did not detect 
significant changes of mRNA expression of A3A and A3G at the three time points 
(P6).  
Among the five patients who responded to treatment, 3D-PCR showed that CA 
samples during the regression course yielded the PCR products at a lower 
denaturation temperature compared to those samples prior to treatment. At the late 
time(6 weeks) of CA regression, denaturation temperature further decreased, ranging 
from 84.9 ºC to 84 ºC, suggesting the existence of more extensive A/T hypermutation 
(Figure 4c). DNA sequencing of the E2 fragments revealed that hypermutation in the 
hyperthermia treated samples was biased toward C to T mutations and G to A 
mutations (Figure 4d). What’s more, patient No. 4 (P4) who showed quick clinical 
response possessed more mutations of E2 gene (Figure 4 e). The patient who failed to 
respond clinically had no obvious biases toward C to T and G to A conversations. The 
association of hyperthermia treatment response, HPV typing and E2 hypermutation is 
an interesting question for further investigation. 
 
Inhibition of A3A or A3G decreased the proportion of A/T in E2 gene 
To investigate the effect of A3A and A3G on the mutation frequency of E2, we 
knocked down the gene using two short-interfering RNA (siRNA) to downregulate 
A3A or A3G expression. Real-time PCR and western blot showed significant decrease 
in mRNA and protein levels after transfection compared with scrambled siRNA 
(Figure 5a-b). In subsequent experiments, CaSki and SiHa cells were pretreated with 
different agents (Scrambled siRNA, A3A-siRNA1, A3A-siRNA2, A3G-siRNA1, or 
A3G-siRNA2) for 72 hours, total DNA was extracted and 3D-PCR was performed. 
Compared with control and scrambled siRNA (85.5 ºC), 3D-PCR products were 
recovered at a higher temperature (86 ºC-87 ºC) in the A3A/G-silenced cells (Figure 
5c). Sequencing of cloned 3D-PCR products revealed that CaSki cells and SiHa cells 
knocking out A3A or A3G produced a relatively low A% and T% in E2 fragments, 
indicating that A3A and 3G contributed to yield hyperedited HPV E2 genomes. 
 
Inhibition of A3A or A3G promoted the viability of cervical cancer cells 
The effect of A3A and A3G on the viability of cervical cancer cells was 
measured by MTS assay from day 1 to day 4. Compared to transfection with 
scrambled siRNA, cell viability was increased with A3A or A3G knockdown at day 3, 
and persisted to day 4 in CaSki cells and SiHa cells. While there was no obvious 
statistical difference of cell viability in C33A cells, either transfected with A3A/G 
siRNA or not (Figure 6). These results indicated that A3A and A3G could regulate the 
cell viability of HPV infected cervical cancer cells. 
 
 
 
 
 
 
 
 
 Discussion 
APOBEC proteins represent a family of cytosine deaminases to resist viral 
infection. During replication, double-stranded DNA viruses may be susceptible to 
deamination yielding G-to-A and C-to-T substitutions (Suspene et al., 2005). Data 
from several laboratories have documented A3 induced hypermutation signatures in 
multiple cancers, including HPV-associated cervical tissues in early stages of cancer 
progression and HPV positive head-and-neck squamous cell carcinomas and 
decreased HPV infectivity (Henderson et al., 2014; Warren et al., 2015). A3A and 
A3G are expressed in epithelial cells, where HPV has been shown to replicate and 
reside (Vartanian et al., 2008). However, information regarding the involvement of 
A3A and A3G in HPV-associated proliferative dermatologic diseases is limited. 
 
It was reported that hyperthermia induce a significant increase of IFN in CA 
(Zhu et al., 2010) and IFN subsequently could positively regulate APOBEC3 
expression (Mehta et al., 2012). A3 was reported to reduce the infectivity of HPV16 
pseudovirion (Ahasan et al., 2015).Our previous study suggested that local 
hyperthermia at 44 ºC in a defined protocol was an effective method to treat 
cutaneous warts (Huo et al., 2010). Local hyperthermia could enhance the production 
of IFNs and increase the apoptotic index of HPV infected skin, partly explaining its 
effectiveness to treat the condition ((Wang et al., 2010; Zhu et al., 2010). One of the 
advantage of local hyperthermia treatment against HPV infected skin is that patients 
with multiple lesions tended to experience clearance of all the lesions, once the 
targeted lesion responded, a phenomenon highly suggestive that local hyperthermia 
aided in the establishment of specific immune response against HPV infected skin. 
Indeed, it was observed that untargeted resolving lesional skin had abundant CD4 and 
CD8+ T cell infiltration (Huo et al., 2013). In the present study, we demonstrated that 
heating/hyperthermia induced A3A and A3G expression in HPV infected cells, and 
their elevated expression was functional to the effect that higher number of HPV E2 
hypermutation was detected. Unexpectedly, hypermutation in HPV E6 was not 
induced (data not shown). We postulate that at least specific genetic sequence may 
render their reactivity with APOBEC3. To our knowledge, HPV LCR DNA was not 
able to be edited by APOBEC (Wang et al., 2014). Detection of other HPV open 
reading frames hypermutation by APOBEC3 is a good topic for further investigation. 
 
Though E2 gene constitutes only a small part of the total viral genome, E2 plays 
an important role in replication and transcription of HPV by binding to specific 
cognate sequences in the viral genome (Sunthamala et al., 2014). Even at relatively 
low levels, the expression of E2 could maintain the cells in a condition compatible 
with viral DNA replication, even induce genomic instability and promote 
carcinogenesis in HPV- associated cervical lesions (Xue et al., 2015b). E2 protein 
may have a great influence on the progression of diseases. Our previous work 
indicated that overexpression of A3A could produce more A/T mutation frequencies 
of HPV E2 gene (Oncology Letter, accepted). On the contrary, insufficient A3A 
resulted in lower A/T mutation frequencies of HPV E2 gene. So we speculate that 
APOBEC3-induced hypermutation of E2 is another mechanism of action that 
hyperthermia took effect to treat HPV infected skin. We detected HPV E2 gene 
mutation in different samples (including cell lines and tissue samples) and found that 
APOBEC edited E2 gene regardless of HPV subtypes. It tends that hyperthermia 
treatment induced stronger APOBEC3 expression and higher E2 mutation rates in 
tissue blocks with low risk HPV types than those with high risk HPV types. A large 
scale clinical trial is required to examine whether HPV types affect the efficacy of 
hyperthermia therapy. Whether hyperthermia could directly induce A3 expression is a 
matter of further investigation. As hyperthermia could induce the production of IFNs, 
and IFNs are known to induce A3 (Payne et al., 2000), an indirect effect of 
hyperthermia on the A3 expression could not be excluded. Regression of HPV 
infected skin is accompanied with dense T cell infiltration. Regressing CA lesions had 
high expression of A3 and high HPV E2 hypermutation. How infiltrating T cells 
correlate with E2 hypermutation is another interesting topic to be further investigated. 
 
 
 
 
 
 
 
 Materials and Methods 
 
Clinical Samples  
Histological evaluation of A3A and A3G proteins were performed on 10 archived, 
formalin fixed and paraffin embedded, histologically confirmed CA tissue blocks at 
the Department of Dermatology, No.1 Hospital of China Medical University. Five 
samples of normal adult skin tissues were collected as controls. 
Genital samples for in vitro study were discarded specimen from 11 patients (3 
males and 8 females) with clinically diagnosed CA and who were treated surgically. 
They had not received any prior anti-wart treatments, and no documented systemic 
disease(s). Five foreskin specimens from patients undergoing genital plastic surgery 
were obtained as normal controls. Serial CA samples were from six CA patients (2 
male and 4 females) with multiple lesions (≧4), again they had not received any prior 
anti-wart treatments, and no any documented systemic disease(s). 
This protocol of collecting human samples was approved by Institutional Review 
Board and was conducted in conform to the Declaration of Helsinki. All samples were 
obtained with informed consent.  
 
Cell culture and hyperthermia 
Human cervical cancer cell lines (C33A, SiHa, CaSki, HeLa and HT3) were 
purchased from ATCC (Manassas, VA) and were cultured as recommended. The 
C33A, SiHa and HT3 cells were maintained in MEM (HyClone, Shanghai, China) 
medium supplemented with 10% fetal bovine serum (FBS, Biological Industries, CT, 
USA). The CaSki and HeLa cells were cultured in RPIM-1640 medium (HyClone, 
Shanghai, China) with 10% FBS. All cell lines were incubated at 37ºC in a humidified 
incubator with 5% CO2. 
Cells were seeded into 6-well plates and cultured overnight before being treated 
with hyperthermia at 37ºC, 42ºC and 45ºC for 30min, then were cultured for another 
12h or 24h and were collected for subsequent RNA and protein testing. 
 
Immunohistochemical study of A3A and A3G 
4 μm paraffin-embedded tissue sections were dewaxed in xylene, rehydrated in 
alcohol, and then incubated with 3% hydrogen peroxide for 10 min to block 
endogenous peroxidase activity. Antigen retrieval was performed by heating pressure 
cooker in 0.01 mol/L citrate buffer (pH, 6.0). The tissue sections were then incubated 
with A3A monoclonal rabbit antibody (dilution 1:1000; Abcam, Cambridge, MA) and 
A3G monoclonal rabbit antibody (dilution 1:200; Abcam) overnight at 4 ºC. After 
rinsing in phosphate-buffered saline (PBS), sections were incubated with biotinylated 
secondary antibody at room temperature for 30 min. Subsequently, sections were 
visualized with the EnVision plus detection system followed by counterstaining with 
hematoxylin. Image-pro Plus software was used to assess the mean optical density.  
 
Heat/Hyperthermia to treat cells or tissues 
A skin organ culture protocol was used in the study (Ostberg et al., 2003) and the 
procedure for local heating has been previously described for vitro experiment (Wang 
et al., 2009; Zhu et al., 2010).  
In regard to in vivo study, six CA patients with multiple lesions received 
hyperthermia treatment at 44 ºC once a day for 3 consecutive days, with each 
treatment session lasting 30 min. A week later, patients subjected to the similar 
treatment for 2 consecutive days，using the hyperthermia device as described (Huo et 
al., 2014; Huo et al., 2013) We chose the biggest lesion in size as therapeutic target. 
Then, the patients were followed-up biweekly to six weeks. Serial biopies were taken 
on untreated lesions, before treatment, 2 weeks and 6 weeks after the first treatment. 
The specimens were embedded in Tissue-Tek® (OCT compound, Sakura, USA) and 
stored at -80 ºC for further analyzes. 
 
Western Blot 
After treatment, the cells were washed twice with PBS and lysed with 80μl RIPA 
buffer (Pierce, Rockford, USA), and 1×complete protease inhibitor cocktail (Roche 
Diagnostics, Mannheim, Germany) on ice for 10min. An aliquot of the total protein 
(30 μg) was loaded into each lane in a 12% sodium dodecyl sulfate polyacrylamide 
gel and then electrophoretically transferred to polyvinylidene difluoride membranes. 
The membrane was blocked with 5% nonfat milk in 0.01M TBS (pH 7.4) and 0.05% 
Tween-20 (TBST) at room temperature for 1 hour before incubation with either 
anti-A3A or A3G antibody at 4 ºC overnight. After washing, the membranes was 
incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody 
(Proteintech, Wuhan, China) for 2 hours at room temperature and the bands were 
visualized with ECL Western Blotting Substrate (Pierce).  
 
RNA isolation and real-time PCR 
Total RNA was extracted by using miRNeasy mini kit (Qiagen, Stockach, 
Germany) and reverse-transcribed with PrimeScript TM RT reagent kit (TaKaRa, 
Ohtsu, Japan). Real-time PCR was performed to calculate relative mRNA expression 
level using primers A3A fwd, 5’-GAAGGGACAAGCACATGGAAGC-3’, and A3A 
rev, 5’-ATCTACTTGATCGGGAGCATAC-3’, A3G fwd, 
5’-GGTGTATTCCGAACTTAAGTAC-3’, and A3G rev, 
5’-CAAGGAAACCGTGTTTATGTGG-3’, GAPDH fwd, 
5’-AAGAGCACAAGAGGAAGAGAGAGAC-3’, and GAPDH rev, 
5’-GTCTACATGGCAACTGTGAGGAG-3’. 
 
RNA isolation and real-time PCR 
    Two siRNAs specific for A3A (A3A siRNA1 and 2) and two siRNAs specific for 
A3G (A3G siRNA1 and 2) as well as scrambled sequence (Scrambled siRNA) were 
purchased from Life Technologies Corporation (Foster City, CA, USA). The siRNA 
sequences are listed in Supplementary Table S2. Cells were seeded the day before 
transfection in antibiotic-free Medium and transfected with Silencer® Select A3A 
siRNA or A3G siRNA and mixed with Lipofectamine™ RNAiMAX (Thermo Fisher 
scientific, USA) as transfection reagent according to the manufacturer's instructions. 
After transfection, cells were assessed for changes in mRNA and protein levels.  
 
Detection of hypermutation in HPV E2 gene 
Genomic DNA was extracted from specimens using DNeasy blood and tissue kit 
(Qiagen) according to the supplier’s instructions. The HPV E2 gene was detected by 
3D-PCR with GoTaq Colorless Master Mix (Promega, Mannheim, Germany) and 
specific primers as previously described (Wang et al., 2014). The initial PCR 
condition was denaturation step at 94 ºC for 4 min, followed by 35 cycles, each 
denaturating at 94 ºC for 16s, annealing at 55 ºC for 20s, extension at 68 ºC for 50s, 
and an additional 10 min extension step at 65 ºC. Second-round PCR was performed 
as follows: 85.9-84 ºC for 5 min, followed by 35 cycles of denaturation at 85.9-84 ºC 
for 45s, annealing at 50 ºC for 30s, extension at 65 ºC for 38s and a final elongation 
step at 65 ºC for 10 min. To analyze the site-specific hypermutation frequency, PCR 
products from 3D-PCR were cloned into T vector and successful recombinant clones 
were selected randomly for further sequencing.  
 
MTS assay 
The cells transfected with A3A-siRNA or A3G-siRNA were seeded in 96-well 
plates at a density of 8000 cells (100μl) per well and at day 1, 2, 3 and 4, 20 μl of 
MTS (Promega, Madison, WI) was added to the medium and then continued 
incubation at 37 ºC for 3 hours. The cell viability was analyzed by measuring the 
absorbance at 490nm using a spectrophotometer.  
 
Statistical analysis 
All experiments were repeated at least three times and statistical analyses were 
performed using GraphPad Prism (GraphPad software, San Diego, CA). For more 
than two groups of experiments, the differences between each group were analysed by 
one-way analysis of variance (ANOVA). Quantitative results were expressed as mean 
± SD. For experiments with only two groups, unpaired t-test, or Mann-Whitney test 
were performed for comparisons of group means. A p value of less than 0.05 was 
considered statistically significant.  
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Figure Legends 
 
Figure 1. Representative examples of immunohistochemical staining of A3A and 
A3G on paraffin-embedded tissue sections. (a) A3A expression increased in CA as 
compared to normal skin. (b) A3G expression enhanced in CA compared with normal 
skin. Scale bar=40μm. Unpaired t-test was performed, yielding a P-value. **p<0.01. 
 
Figure 2 APOBEC3A (A3A) and A3G expression increased after exposure to 
hyperthermia in a temperature-dependent manner. After exposure to specific 
hyperthermia, A3A and A3G mRNA expression were evaluated in CaSki, SiHa and 
C33A cells at 12 hours of hyperthermia treatment, and equivalent protein expression 
were assessed at 24 hours. (a,b) A3A and A3G mRNA levels increased at 42 ºC and 
45 ºC in CaSki, SiHa and C33A cells. (c) A3A and A3G protein levels showed similar 
results.(d,e) A3A and A3G levels were measured between healthy controls and CA 
subjected to hyperthermia at 37 ºC, 42 ºC and 45 ºC in vivo. Each symbol represents 
on individual donor. Horizontal bars represent means. One-way analysis of variance 
(ANOVA) and Mann-Whitney test were performed, yielding a P-value for all 
comparisons. *p<0.05; **p<0.01 and ***p<0.001. 
 
Figure 3 3D-PCR analysis of the HPV16 E2 gene in cervical cell lines subjected 
to hyperthermia treatment. Hyperthermia caused increased A3A and A3G-induced 
mutations as compared with controls. (a) E2 3D-PCR assays were performed to 
analyze the amplification products at a lower denaturation temperature in CaSki and 
SiHa cells. (b) The number of mutations for the edited HPV16E2 genomes was shown 
below the matrix in cervical cells treated with hyperthermia.  
 
Figure 4 Regressing CA lesions receiving hyperthermia elevated mRNA 
expression of APOBEC3A (A3A) and A3G. (a,b) A3A and A3G mRNA expression 
in 6 CA patients treated with hyperthermia at 0min, 2 weeks, and 6 weeks, as 
measured by real-time PCR in vivo. (c) The total DNA samples from CA treated with 
hyperthermia at 0min, 2 weeks, and 6 weeks were analyzed in the E2 3D-PCR assay. 
(d,e) Summary of 3D-PCR amplicon sequences were shown as mutation matrices in 
the No. 4 (P4) presented with quick clinical response (e) and the other 5 patients (d). 
 
Figure 5 Inhibition of A3A or A3G decreased the proportion of A/T in E2 gene. 
The CaSki cells and SiHa cells were transfected with scrambled siRNA, two different 
A3A-specific siRNAs, and two different A3G-specific siRNAs, respecively. (a,b) 
Real-time PCR results and western blot analysis results were shown that both the A3A 
siRNAs downregulated the expression of A3A and the two A3G siRNAs inhibited the 
expression of A3G significantly. (c) The total DNA was extracted from CaSki cells 
and SiHa cells after transfection with siRNAs for 72 hours, and 3D-PCR results was 
shown that the A3A-siRNAs or A3G-siRNAs upregulated the denaturation 
temperature in HPV E2 sites. (d) Summary of 3D-PCR amplicon sequences were 
presented as mutation matrices.  
 Figure 6 Downregulation of A3A or A3G increased the cell viability of cervical 
cancer cells. CaSki , SiHa and C33A cells transiently downregulated A3A or A3G 
were cultured in 96-well plates. Cell viability was measured by MTS assay at day 1, 2, 
3 and 4 as described under the Materials and Methods.  
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